HeartSTAT Technology, Inc. Appoints Mr. Ted Russell as CEO and Director of Technology

Mr. Russell Will Also Hold a Board Position With The Company


LOS ANGELES, July 27, 2004 (PRIMEZONE) -- HeartSTAT Technology, Inc. (Pink Sheets:HSTA) today announced that Mr. Ted Russell has been appointed by the shareholders as the company's CEO and Director of Technology. Mr. Russell will also hold an active seat on the Board of Directors.

In March of 2004, Mr. Russell, founder of HeartSTAT, Inc., completed an acquisition merger listing the HeartSTAT Technology as the primary asset and business interest of the company.

Mr. Russell invented the HeartSTAT Technology and has been managing the development of its systems and related medical technologies for fifteen years. In addition, he has fourteen years experience as CEO of computer and medical device companies and in corporate governance as board chairman and CFO. Mr. Russell has also held a position as senior general management consultant for Booz, Allen & Hamilton, for which he managed major engagements for General Electric, Federal Express, and WT Grant. As well, he was CEO of a $250 million Memorex Corporation affiliate; directed three new computer system and medical device product marketing rollouts; and held financial controllership positions at Eastman Kodak. Mr. Russell received a BSE degree from University of Michigan in 1965 and MBA degree from Columbia University in 1974.

About HeartSTAT Technology, Inc.

HeartSTAT Technology, Inc. and its subsidiary HeartSTAT Inc. is commercializing the first practical system for monitoring blood flow, perfusion (oxygen transport), and cardiovascular dynamics. This is a much needed technology as physicians and other care providers are regularly misled about abnormal blood flow conditions and cardiovascular diseases.

More information on HeartSTAT Technology, Inc. (Pink Sheets:HSTA) can be found at www.HeartSTAT.com.

Statements in this release are made pursuant to the "Safe Harbor" provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risk and uncertainties including, without limitation, continued acceptance of the Company's services, increased levels of competition for the Company and dependence on the performance of the Management of the Company.


            

Coordonnées